Home » Report Says Counterfeit Medicines On Rise Worldwide
A report by the Pharmaceutical Security Institute recorded more than 2,000 incidents of counterfeit medicines in 2009, an increase of more than nine percent from the previous year.
The Group's Director for Europe, Middle East and Africa, Ashley How, says the true scope of the problem is unknown. He says counterfeiters use many ruses to manufacture and move their products around the world. "Most counterfeiters will, because if you think of the required skill that goes into the production of a medicine in order to fool the health authorities, to fool the public, to fool law enforcement, they have to be of a good quality ... So, therefore what they do not want are law enforcement after them too soon, and so they will often put the active ingredient into the actual production," How said.
Countries such as India and Brazil, which are major manufacturers of generic drugs, accuse the pharmaceutical industry of using the issue of counterfeit drugs to protect their patents against generic competitors. They say the World Health Organization is helping this effort. The Director of WHO's Essential Medicines Program, Hendrick Hogerzeil, refutes these charges.
"Our stated goal is very clear," Dr. Hogerzeil said. "We do not want any counterfeit discussion to block the trade in, what we call, legitimate generic medicines and WHO is not going in IPR enforcements. We go for the public health and leave the other thing to WIPO (World Intellectual Property Organization) and WTO (World Trade Organization) and the countries themselves."
"So, therefore, the active ingredient has to move around the world." Dr. Hogerzeil says counterfeit drugs are sold in all countries. But he says rich countries are more successful at regulating and policing these sales than are poor countries. "We are not so worried about, if I were to be honest about it, we are not so worried about falsified Viagra," Dr. Hogerzeil said. "We are worried about falsified malaria medicines, falsified AIDS medicines that poor people could buy that enter the markets and, in the end, do not treat the people and kill them."
I want to hear from you. Tell me how we can improve.
This month in Security magazine, we highlight COVID-19 and enterprise security's response. How has the pandemic changed business continuity plans, and what lessons have been learned? Also this month, we profile Chris Hallenbeck, CISO at Tanium, his view on metrics and information security. In addition, security experts discuss video analytics, how to make AI work within your cyber strategy and more.